Tutte le categorie
| Product Name | Descrizione | Action |
|---|---|---|
| Denosumab | Trade Name : Prolia Target : RANK ligand Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 3360(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with ... |
|
| Infliximab, Remicade, CA2, TA-650, Biologico anti- TNF / inibitore del TNF, Anticorpo monoclonale chimerico, Terapeutico autoimmune / Biologico reumatologico, Infusione endovenosa, CAS n. 170277-31-3 | Trade Name : Remicade Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 4100 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Pembrolizumab | Trade Name : Keytruda Target : PD-1 Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 30990 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Bevacizumab | Trade Name : Avastin Target : VEGF Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : N/A All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Vedolizumab,Entyvio,MLN0002,Anti-integrina biologico,Anticorpo monoclonale IgG1 umanizzato,Terapeutico per IBD / Colite ulcerosa biologico / Biologico per la malattia di Crohn, CAS n. 943609-66-3 | Trade Name : Entyvio Target : N/A Molecular Type : N/A Sales in 2025 (Millions of USD) : N/A All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Imiglucerase, Cerezyme, rGCR, GBA (β-glucocerebrosidasi), Glicoproteina (Questa è una proteina contenente 497 amminoacidi, prodotta mediante tecnologia del DNA ricombinante), N. CAS 154248-97-2 | Trade Name : Cerezyme® Target : GBA (β- glucocerebrosid ase) Molecular Type : Glycoprotein (This is a protein containing 497 amino acids, produced using recombinant DNA technology) Sales in 2025 (Millions of USD) : 1105(estimate) All detailed product information shall be subject to the issued final ... |
|
| Luspatercept-aamt,Reblozyl,ACE-536, Proteina di fusione ricombinante, Trappola del recettore dell' activina, Ligandi della superfamiglia del fattore di crescita-β (TGF-β), Proteina di fusione ricombinante | Trade Name : Reblozyl Target : Transforming growth factor-β (TGF- β)superfamily ligands Molecular Type : Recombinant Fusion Protein Sales in 2025 (Millions of USD) : 2000 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for ... |
|
| Relatlimab, Opdualag, BMS-986016, Inibitore del punto di controllo immunitario anti-LAG-3, Gene di attivazione dei linfociti- 3 (LAG-3), Anticorpo monoclonale all' immunoglobulina umana G4 (IgG4), CAS n. 1673516-98-7 | Trade Name : Opdualag Target : Lymphocyte- activation gene- 3 (LAG-3) Molecular Type : Humanized Immunoglobulin G4 (IgG4) Monoclonal Antibody Sales in 2025 (Millions of USD) : 1358 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentati... |
